CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- POS AM Other Post-effective Amendment for Registration Statement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 424B3 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Other events
- 8-K Event Executive or director change · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 13,000 shares at $3.22 ($41,850)
- 4/A Open-market buy Chief Executive Officer bought 10,000 shares at $5.00 ($50,000)
- 4/A Conversion SVP of R&D acquired 26,587 shares (conversion)
Page 12 of 16 · 309 filings